Retain ‘sell’ on Sun Pharma, expect pricing to collapse

At its 1QCY16 results, Novartis indicated it expected Gleevec to emerge as a four-to-six-player generic market in 3QCY16, in line with our contrarian view of at least four generic players competing on day-181.

https://www.financialexpress.com/ar...sun-pharma-expect-pricing-to-collapse/242917/